These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 843956)

  • 1. Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa.
    Kostrzewa RM; Garey RE
    Brain Res; 1977 Mar; 124(2):385-91. PubMed ID: 843956
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of hypertrophied locus coeruleus projection to adult cerebellum after neonatal 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Aug; 172(1):23-33. PubMed ID: 466465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic hyperinnervation reduces the density of beta-adrenergic receptors in rat cerebellum.
    Harden TK; Mailman RB; Mueller RA; Breese GR
    Brain Res; 1979 Apr; 166(1):194-8. PubMed ID: 217500
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM; Klara JW; Robertson J; Walker LC
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A light and electron microscopic study of noradrenergic terminals in the rat dentate gyrus.
    Koda LY; Bloom FE
    Brain Res; 1977 Jan; 120(2):327-35. PubMed ID: 832125
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
    Harston CT; Morrow A; Kostrzewa RM
    Brain Res Bull; 1980; 5(4):421-4. PubMed ID: 7407638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain.
    Jacobowitz D; Kostrzewa R
    Life Sci I; 1971 Dec; 10(23):1329-42. PubMed ID: 5144293
    [No Abstract]   [Full Text] [Related]  

  • 11. Degeneration of noradrenergic nerve terminals in submucous ganglia of the rat duodenum following treatment with 6-hydroxydopamine.
    Wong WC; Helme RD; Smith GC
    Experientia; 1974 Mar; 30(3):282-4. PubMed ID: 4824608
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of neurotransmitters from rat brain nerve terminals after chronic ethanol ingestion: differential effects in cortex and hippocampus.
    Sabriá J; Torres D; Pastó M; Peralba JM; Allali-Hassani A; Parés X
    Addict Biol; 2003 Sep; 8(3):287-94. PubMed ID: 13129830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered responsiveness of adenosine 3',5'-monophosphate-generating systems in brain slices from adult rats after neonatal treatment with 6-hydroxydopamine.
    Dismukes RK; Daly JW
    Exp Neurol; 1975 Oct; 49(1 Pt 1):150-60. PubMed ID: 171170
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):309-19. PubMed ID: 34469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
    Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
    [No Abstract]   [Full Text] [Related]  

  • 19. Choline acetyltransferase activity increases in the brain stem of rats treated at birth with 6-hydroxydopa.
    Jaim-Etcheverry G; Teitelman G; Zieher LM
    Brain Res; 1975 Dec; 100(3):699-704. PubMed ID: 1192203
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical periods for noradrenergic regeneration in rat brain regions following neonatal subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Life Sci; 1979 Nov; 25(19):1641-50. PubMed ID: 513971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.